Literature DB >> 2936528

Preservation of endothelium-dependent vascular relaxation in cholesterol-fed rabbit by treatment with the calcium blocker PN 200110.

J B Habib, C Bossaller, S Wells, C Williams, J D Morrisett, P D Henry.   

Abstract

We tested the effects of low doses of a dihydropyridine calcium antagonist, PN 200110, on endothelium-dependent vascular relaxation in rabbits fed a 1% cholesterol diet. The drug was given orally, 1 mg/day, and control rabbits received placebo. Plasma total cholesterol after 10 weeks, was similar in the placebo- and PN 200110-treated groups. The respective values averaged 2140 +/- 116 (n = 14; mean +/- SEM) and 2012 +/- 115 mg/dl (n = 13). In placebo-treated rabbits, sudanophilic aortic lesions covered 52 +/- 5% of the intimal surface, and the aortic cholesterol concentration was 72 +/- 6 mg/g protein. Corresponding values in aortas from PN 200110-treated rabbits were significantly lower [36 +/- 5% (P less than 0.03) and 52 +/- 3 mg/g protein (P less than 0.03)]. Maximal endothelium-dependent cholinergic relaxation of aortic strips in untreated (n = 14) and treated cholesterol-fed rabbits (n = 13) differed significantly (P less than 0.01) and averaged 31 +/- 4% and 61 +/- 7% of the value in normocholesterolemic controls (n = 13). We conclude that cholesterol feeding suppresses endothelium-dependent relaxation evoked by acetylcholine, and that PN 200110 reduces the severity of atherosclerosis and impairment of endothelium-dependent relaxation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2936528     DOI: 10.1161/01.res.58.2.305

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  30 in total

Review 1.  Lipids and endothelium-dependent vasodilation--a review.

Authors:  Lars Lind
Journal:  Lipids       Date:  2002-01       Impact factor: 1.880

Review 2.  Antiatherogenic effects of calcium-channel blockers: possible mechanisms of action.

Authors:  P D Henry
Journal:  Cardiovasc Drugs Ther       Date:  1990-08       Impact factor: 3.727

Review 3.  Pharmacology of the calcium antagonist isradipine.

Authors:  U T Rüegg; R P Hof
Journal:  Drugs       Date:  1990       Impact factor: 9.546

4.  Endothelium-dependent responses in autogenous femoral veins grafted into the arterial circulation of the dog.

Authors:  V M Miller; M M Reigel; L H Hollier; P M Vanhoutte
Journal:  J Clin Invest       Date:  1987-11       Impact factor: 14.808

5.  Reduction of intimal hyperplasia and enhanced reactivity of experimental vein bypass grafts with verapamil treatment.

Authors:  M N el-Sanadiki; K S Cross; J J Murray; R W Schuman; E Mikat; R L McCann; P O Hagen
Journal:  Ann Surg       Date:  1990-07       Impact factor: 12.969

6.  Restoration of endothelium-dependent relaxation by dietary treatment of atherosclerosis.

Authors:  D G Harrison; M L Armstrong; P C Freiman; D D Heistad
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

7.  N-nitro L-arginine causes coronary vasoconstriction and inhibits endothelium-dependent vasodilatation in anaesthetized greyhounds.

Authors:  O L Woodman; G J Dusting
Journal:  Br J Pharmacol       Date:  1991-06       Impact factor: 8.739

8.  Effect of controlled adventitial heparin delivery on smooth muscle cell proliferation following endothelial injury.

Authors:  E R Edelman; D H Adams; M J Karnovsky
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

9.  Hypercholesterolaemia severely impairs EDRF-dependent collateral perfusion following acute arterial occlusion in rabbit isolated ear.

Authors:  M D Randall; J A Smith; T M Griffith
Journal:  Br J Pharmacol       Date:  1993-07       Impact factor: 8.739

10.  L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans.

Authors:  M A Creager; S J Gallagher; X J Girerd; S M Coleman; V J Dzau; J P Cooke
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.